LGALS3BP and colonic neoplasm: Importantly, recombinant LGALS3BP was demonstrated to inhibit neutrophil activation and siRNA-mediated reduction of LGALS3BP expression in HT-29 colon cancer cells increased neutrophil-induced apoptosis of the HT-29 cells (166).